(NYSE: BSX) Boston Scientific's forecast annual revenue growth rate of 4.33% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.96%.
Boston Scientific's revenue in 2026 is $20,996,000,000.On average, 34 Wall Street analysts forecast BSX's revenue for 2026 to be $31,170,028,645,208, with the lowest BSX revenue forecast at $29,748,334,480,202, and the highest BSX revenue forecast at $32,814,904,157,218. On average, 34 Wall Street analysts forecast BSX's revenue for 2027 to be $32,487,378,284,342, with the lowest BSX revenue forecast at $30,754,099,771,246, and the highest BSX revenue forecast at $34,874,259,313,664.
In 2028, BSX is forecast to generate $34,729,336,361,064 in revenue, with the lowest revenue forecast at $32,406,221,430,886 and the highest revenue forecast at $37,271,284,949,668.